• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX

    12/19/24 10:09:23 AM ET
    $IDXX
    $SNPS
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $IDXX alert in real time by email

    BOSTON, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Sustainability Roundtable, Inc. (SR Inc), a leader in strategic advisory and support services, proudly announces the recipients of its 2024 Sustainable Business & Enterprise Roundtable (SBER) Awards. Presented the eve before its Summit for Sustainable Business VIII: Decarbonizing Corporate Global Operations at the St. Regis hotel in Washington, D.C., these recognitions commemorate SBER's 2024 standout sustainability leaders.

    Award Recipients and Achievements

    SR Inc is delighted to recognize the following SBER Member-Clients and Implementing Executives for their accomplishments in 2024.

    1. Synopsys: Outstanding Corporate Leader

    Synopsys, Inc. (NASDAQ:SNPS), a leading provider of comprehensive silicon to systems design solutions, earned recognition for its exceptional commitment to renewable energy procurement and comprehensive sustainability initiatives.

    image1.jpg

    Erika Varga McEnroe, Senior Vice President and Deputy General Counsel for Synopsys, accepts the Outstanding Corporate Leader Award on behalf of Synopsys

    Key achievements:

    • Established a strong near-term Science-Based Target (SBT) with concrete implementation plans
    • Signed a significant Virtual Power Purchase Agreement (VPPA) for 90MW of the Millers Branch 3 project with the Net Zero Consortium for Buyers (NZCB), following a previous 15MW agreement for Azure Sky
    • Actively participated in SBER research on function design, sustainably healthy workplaces, and gaining buy-in for decarbonization initiatives

    Erika Varga McEnroe, Senior Vice President and Deputy General Counsel at Synopsys, accepted the award on behalf of the company. McEnroe played a crucial role in negotiating the Millers Branch 3 VPPA. We would also like to thank Eugene Brown, Sustainability & ESG Director, for his crucial work on decarbonization targets, implementation plans, and clean energy procurement.

    2. Nell Triplett, Juniper Networks: Outstanding Executive

    Nell Triplett, Director of Sustainability at Juniper Networks, a leader in secure, AI-Native Networking, was honored for her outstanding leadership in corporate sustainability and renewable energy initiatives.

    image3.jpg

    Nell Triplett, Director of Sustainability at Juniper Networks, accepts the Outstanding Corporate Executive Award

    Notable contributions:

    • Secured approval for Juniper Networks' Science-Based Target
    • Led Juniper's participation in an aggregated VPPA for 40MW of the Millers Branch 2 project with the NZCB
    • Collaborated extensively on SBER research projects, including strategies for gaining buy-in for decarbonization initiatives and mandatory reporting

    3. IDEXX: Breakthrough Corporate Leader

    IDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in veterinary diagnostics and software, earned the award for its rapid progress in environmental sustainability. Mike Connolly, Sr. Manager of Global Facilities Engineering, and Pat O'Brien, Director of Global Operations, accepted the award on the organization's behalf. We also congratulate IDEXX's Sustainability Program Manager, Dan Wojciechowski, who could not attend the event but significantly contributed to IDEXX's sustainability efforts.

    image2.jpg

    Mike Connolly, Sr. Manager of Global Facilities Engineering, and Pat O'Brien, Director of Global Operations, accept the Breakthrough Corporate Leader Award on behalf of IDEXX

    Key accomplishments:

    • Contributed to SBER research on Scope 1 decarbonization and strategies for gaining buy-in for decarbonization initiatives
    • Completed a VPPA for 20MW of the Millers Branch 2 project with the NZCB
    • Actively participated in additional aggregated procurements for purchaser-caused renewable electricity in the U.S. and Europe

    Fostering environments for candid, practical conversations among Member-Client executives is critical to how SBER drives shared progress. We'd like to recognize this year's awardees for their valuable insights at SBER research interviews, Symposia, and Summits throughout the year. Each implementing individual mentioned epitomized the pragmatic, collaborative spirit that illuminates the SBER ethos.

    Congratulations to all awardees. We look forward to continuing to partner with these leaders on enterprise decarbonization efforts in 2025!

    About SR Inc and the Sustainable Business & Enterprise Roundtable (SBER)

    SR Inc works to be the world's most respected strategic advisor in enterprise decarbonization. For more than fifteen years, leaders at over 100 Fortune 500 and global growth companies have trusted SR Inc to provide membership-based strategic advisory and support services. SBER helps executives set goals, drive progress, and report results in enterprise decarbonization as they lead their organizations to more sustainable high performance — to help align business with life.

    About the Net Zero Consortium for Buyers (NZCB)

    The NZCB is a confidential renewable energy buyers' community that creates transactions favorable for corporate buyers. The NZCB enables enterprises to chart a profitable path to Net Zero emissions globally. SR Inc Member-Clients have made the NZCB a leading transaction platform for corporate aggregated utility-scale renewable energy procurement in North America and Europe. NZCB participants are democratizing the financial and environmental benefits of utility-scale clean energy.

    Inquiries

    To learn more about SR Inc., the SBER Awards, or sustainable business practices, email [email protected]. For media inquiries, contact [email protected].

    Photos accompanying this announcement are available at

    https://www.globenewswire.com/NewsRoom/AttachmentNg/65dcd4bf-c208-41b9-b290-36b3a0129bdc

    https://www.globenewswire.com/NewsRoom/AttachmentNg/92cede96-c015-43e6-8dd2-ccf8cf88f7ff

    https://www.globenewswire.com/NewsRoom/AttachmentNg/d506bca7-fe8c-42d7-9812-dca65a690e3f



    Primary Logo

    Get the next $IDXX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IDXX
    $SNPS

    CompanyDatePrice TargetRatingAnalyst
    Synopsys Inc.
    $SNPS
    2/27/2026$480.00Overweight → Equal-Weight
    Morgan Stanley
    Synopsys Inc.
    $SNPS
    2/20/2026$455.00Buy → Hold
    HSBC Securities
    Synopsys Inc.
    $SNPS
    1/13/2026$520.00Overweight → Neutral
    Piper Sandler
    Synopsys Inc.
    $SNPS
    12/11/2025$560.00Neutral → Buy
    BofA Securities
    IDEXX Laboratories Inc.
    $IDXX
    12/9/2025$850.00Overweight
    Barclays
    Synopsys Inc.
    $SNPS
    12/9/2025$560.00Neutral → Buy
    Rosenblatt
    Synopsys Inc.
    $SNPS
    12/8/2025$500.00Underperform → Neutral
    BofA Securities
    Synopsys Inc.
    $SNPS
    11/24/2025$580.00Buy
    Citigroup
    More analyst ratings

    $IDXX
    $SNPS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma

    Helping clinicians investigate sooner and plan next steps with confidence IDEXX Laboratories, Inc. (NASDAQ:IDXX), a global leader in pet healthcare innovation, today announced the availability of the IDEXX Cancer Dx™ Panel in the United Kingdom, beginning with early detection of lymphoma in at-risk* dogs. The blood test can be added to panels for sick pets and integrated into regular wellness screenings, with veterinarian pricing starting from £22.50† and results available to UK practices within 3–5 business days. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260401831720/en/IDEXX Cancer Dx Panel with lymphoma testing Cancer

    4/1/26 3:00:00 AM ET
    $IDXX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Synopsys Supports New Arm AGI CPU with Full-Stack Design Solutions

    Arm and Synopsys partnership extended to new Arm data center CPU, including EDA, IP, and Hardware-Assisted Verification SolutionsKey HighlightsSynopsys' broad portfolio of design, analysis, and verification solutions available on Arm-based architecture enables data center-class requirements and low total cost of compute during developmentSynopsys silicon-proven interface IP solutions deliver reliable high-performance design implementation to support compute subsystemsSynopsys high-performance emulation and prototyping systems enable IP and subsystem bring-up and system-level verification for complex data center workloadsSUNNYVALE, Calif., March 24, 2026 /PRNewswire/ -- Synopsys, Inc. (NASDAQ

    3/24/26 1:15:00 PM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology

    Synopsys Showcases NVIDIA Partnership Impact and Ecosystem Innovation at GTC 2026

    Customers across industries are revolutionizing product design and accelerating innovation with NVIDIA-accelerated engineering solutions from SynopsysKey Highlights Synopsys is building an open, secure, hardware accelerated agentic AI stack in collaboration with NVIDIA to cater to use cases from silicon to systems Applied Materials collaborates with Synopsys to accelerate complex quantum chemistry simulations for large-scale dynamic materials modeling by up to 30X using Synopsys QuantumATK® optimized with NVIDIA cuESTHonda enabled practical, high-fidelity CFD using four GB200s, achieving 34X faster computation and 38X cost reduction compared to 1,920 cloud-based CPU coresAstera Labs accelera

    3/16/26 4:30:00 PM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology

    $IDXX
    $SNPS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Synopsys downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Synopsys from Overweight to Equal-Weight and set a new price target of $480.00

    2/27/26 8:29:50 AM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology

    Synopsys downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded Synopsys from Buy to Hold and set a new price target of $455.00

    2/20/26 9:56:23 AM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology

    Synopsys downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Synopsys from Overweight to Neutral and set a new price target of $520.00

    1/13/26 9:07:49 AM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology

    $IDXX
    $SNPS
    SEC Filings

    View All

    SEC Form DEFA14A filed by IDEXX Laboratories Inc.

    DEFA14A - IDEXX LABORATORIES INC /DE (0000874716) (Filer)

    3/27/26 4:00:58 PM ET
    $IDXX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form DEF 14A filed by IDEXX Laboratories Inc.

    DEF 14A - IDEXX LABORATORIES INC /DE (0000874716) (Filer)

    3/27/26 4:00:23 PM ET
    $IDXX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Synopsys Inc.

    SCHEDULE 13G/A - SYNOPSYS INC (0000883241) (Subject)

    3/27/26 1:20:06 PM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology

    $IDXX
    $SNPS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Kankanwadi Sudhindra converted options into 793 shares and covered exercise/tax liability with 288 shares, increasing direct ownership by 2% to 22,219 units (SEC Form 4)

    4 - SYNOPSYS INC (0000883241) (Issuer)

    3/16/26 7:06:00 PM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology

    CFO Glaser Shelagh converted options into 793 shares and covered exercise/tax liability with 282 shares, increasing direct ownership by 3% to 18,381 units (SEC Form 4)

    4 - SYNOPSYS INC (0000883241) (Issuer)

    3/16/26 6:58:55 PM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology

    PRESIDENT AND CEO Ghazi Sassine converted options into 1,322 shares and covered exercise/tax liability with 458 shares, increasing direct ownership by 1% to 75,020 units (SEC Form 4)

    4 - SYNOPSYS INC (0000883241) (Issuer)

    3/16/26 6:53:57 PM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology

    $IDXX
    $SNPS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Painter Robert G bought $148,904 worth of shares (350 units at $425.44), increasing direct ownership by 18% to 2,291 units (SEC Form 4)

    4 - SYNOPSYS INC (0000883241) (Issuer)

    9/15/25 7:19:16 PM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology

    Casper Marc N bought $439,087 worth of shares (750 units at $585.45), increasing direct ownership by 76% to 1,736 units (SEC Form 4)

    4 - SYNOPSYS INC (0000883241) (Issuer)

    3/27/24 11:12:13 AM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology

    $IDXX
    $SNPS
    Leadership Updates

    Live Leadership Updates

    View All

    Synopsys Appoints Former Deloitte Executive Peter Shimer to Board of Directors and Announces Board Transitions

    SUNNYVALE, Calif., Feb. 19, 2026 /PRNewswire/ -- Synopsys, Inc. (NASDAQ:SNPS) today announced the appointment of Peter A. Shimer to its board of directors. Shimer brings four decades of experience at international public accounting firm Deloitte where he held numerous executive roles, including serving as its interim chief executive officer (CEO). During his tenure on the Deloitte executive committee and under his financial stewardship, the firm increased annual revenue by more than 135% to $30 billion. Shimer's appointment is effective immediately, and he will serve on the board's audit committee.

    2/19/26 4:01:00 PM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology

    Edgewater Wireless Issues 2026 Corporate Update

    "Wi-Fi8 Before Wi-Fi8" – Accelerating Wi-Fi8-ready Spectrum Slicing™ Silicon with Silicon Catalyst Ecosystem, Arm, Synopsys and FABrIC Support Edgewater Wireless Systems Inc. (TSXV:YFI) (OTC:KPIFF), the industry pioneer of AI-powered Wi-Fi Spectrum Slicing™ silicon solutions and IP for residential, enterprise and Industrial IoT markets, today issued a corporate update outlining the Company's material progress over the past 12 months and its 2026 execution roadmap toward Wi-Fi8-ready silicon deliverables and strategic commercialization. Over the last year, Edgewater has evolved from an innovation-led Wi-Fi disruptor into a globally recognized reliability and low-latency thought leader, a

    2/5/26 7:01:00 AM ET
    $ARM
    $SNPS
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    Synopsys Appoints Mike Ellow as Chief Revenue Officer

    SUNNYVALE, Calif., Nov. 19, 2025 /PRNewswire/ -- Synopsys, Inc. (NASDAQ:SNPS) today announced that Mike Ellow is joining the company as Chief Revenue Officer, effective November 20. In this role, he will lead the company's Go-To-Market organization and join the executive leadership team, reporting to President and CEO Sassine Ghazi. Ellow joins from Siemens EDA, Siemens Digital Industries Software, where he served as Chief Executive Officer. He brings more than 30 years of executive leadership in sales and technical management, including leadership roles at Cadence Design Syst

    11/19/25 9:00:00 AM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology

    $IDXX
    $SNPS
    Financials

    Live finance-specific insights

    View All

    Synopsys Posts Financial Results for First Quarter Fiscal Year 2026

    Results SummaryQuarterly revenue of $2.409 billion, at high-end of prior guidance; quarterly GAAP earnings per diluted share (EPS) of $0.34, and non-GAAP earnings per diluted share of $3.77 above prior guidanceReiterating expectations for full-year total revenue of $9.61 billion at the midpoint, including $2.9 billion of expected Ansys revenueSynopsys' board of directors approved a replenishment of the existing stock repurchase program with authorization to purchase up to $2.0 billion of Synopsys common stockSUNNYVALE, Calif., Feb. 25, 2026 /PRNewswire/ -- Synopsys, Inc. (Nasdaq: SNPS) today reported results for its first quarter of fiscal year 2026. Revenue for the first quarter of fiscal y

    2/25/26 4:05:00 PM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology

    IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results

    Achieves fourth quarter revenue growth of 14% as reported and 12% organic, reflecting strong CAG Diagnostics recurring revenue, growing 12% reported and 10% organic. Strong organic growth benefits from IDEXX execution and commercial performance, including over 1,900 IDEXX inVue Dx™ placements, delivering a quarterly record of instrument placements and 12% year-over-year expansion of IDEXX's global premium instrument installed base. Delivers fourth quarter EPS of $3.08, an increase of 18% as reported and 17% on a comparable basis, supported by operating margin expansion of 150 basis points as reported and 120 basis points on a comparable basis. Provides initial outlook for 2026 re

    2/2/26 6:30:00 AM ET
    $IDXX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Synopsys Announces Earnings Release Date for First Quarter Fiscal Year 2026

    SUNNYVALE, Calif., Jan. 27, 2026 /PRNewswire/ -- Synopsys, Inc. (NASDAQ:SNPS) today announced it will report results for the first quarter fiscal year 2026 on Wednesday, February 25, 2026, after market close. The company will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to review its financial results and business outlook. Financial and other statistical information to be discussed on this conference call will be available on the corporate website at www.investor.synopsys.com immediately before the call. A live webcast will also be available on thi

    1/27/26 4:05:00 PM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology

    $IDXX
    $SNPS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by IDEXX Laboratories Inc.

    SC 13G/A - IDEXX LABORATORIES INC /DE (0000874716) (Subject)

    11/12/24 3:48:28 PM ET
    $IDXX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: SEC Form SC 13G/A filed by IDEXX Laboratories Inc.

    SC 13G/A - IDEXX LABORATORIES INC /DE (0000874716) (Subject)

    11/4/24 11:47:05 AM ET
    $IDXX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form SC 13G/A filed by IDEXX Laboratories Inc. (Amendment)

    SC 13G/A - IDEXX LABORATORIES INC /DE (0000874716) (Subject)

    2/13/24 5:06:19 PM ET
    $IDXX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care